We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.
Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method
© Peters and Sette; licensee BioMed Central Ltd. 2005
- Received: 21 January 2005
- Accepted: 31 May 2005
- Published: 31 May 2005
Many processes in molecular biology involve the recognition of short sequences of nucleic-or amino acids, such as the binding of immunogenic peptides to major histocompatibility complex (MHC) molecules. From experimental data, a model of the sequence specificity of these processes can be constructed, such as a sequence motif, a scoring matrix or an artificial neural network. The purpose of these models is two-fold. First, they can provide a summary of experimental results, allowing for a deeper understanding of the mechanisms involved in sequence recognition. Second, such models can be used to predict the experimental outcome for yet untested sequences. In the past we reported the development of a method to generate such models called the Stabilized Matrix Method (SMM). This method has been successfully applied to predicting peptide binding to MHC molecules, peptide transport by the transporter associated with antigen presentation (TAP) and proteasomal cleavage of protein sequences.
Herein we report the implementation of the SMM algorithm as a publicly available software package. Specific features determining the type of problems the method is most appropriate for are discussed. Advantageous features of the package are: (1) the output generated is easy to interpret, (2) input and output are both quantitative, (3) specific computational strategies to handle experimental noise are built in, (4) the algorithm is designed to effectively handle bounded experimental data, (5) experimental data from randomized peptide libraries and conventional peptides can easily be combined, and (6) it is possible to incorporate pair interactions between positions of a sequence.
Making the SMM method publicly available enables bioinformaticians and experimental biologists to easily access it, to compare its performance to other prediction methods, and to extend it to other applications.
- Major Histocompatibility Complex
- Prediction Method
- Major Histocompatibility Complex Molecule
- Randomize Peptide Library
- Major Histocompatibility Complex Binding
Whenever experimental data is gathered to examine a process, researchers will try – implicitly or explicitly – to define a model describing the process. The purpose of building a model is to generalize the experimental data, allowing the prediction of new experimental outcomes, or to gain insights into the experimental process. In the biological sciences, models are often implicitly built and verbally formulated, such as "the proteasome preferably cleaves after hydrophobic amino acids". Such a model is easy to understand and often reflects all the knowledge that can be gathered from a few, difficult experiments. However, with the advent of high-throughput experiments to the biosciences, it has become feasible to generate more quantitative, mathematical models, based on large volumes of data. For the purpose of building a model, conducting experiments can be formally described as collecting pairs of experimental parameters x and experimental outcomes (measurements: ymeas). Building a model is then equivalent to finding a function f(x) = ypred ≈ ymeas. Herein, we call the model function f a prediction tool, and the experimental observations used to generate it its training set T = (x, ymeas).
Developing a prediction tool is a two step process. First, a general prediction method capable of generating specific tools has to be chosen, such as a certain type of neural network, classification tree, hidden markov model or regression function. This choice is to some degree determined by the experimental data available. However, only a few prediction methods are clearly unsuited for a certain type or amount of data, leaving several potentially appropriate methods to choose from. In practice, the personal experience of a scientist often determines which prediction method he applies, as learning to apply a new method is often more costly than the benefits of a slightly better model.
After a method is chosen, it is applied to the experimental data to generate a specific prediction tool. Several different terms are commonly used for this second step, such as 'supervised learning', 'fitting the model' or 'regression'. Each method has its own formalism describing how this is done, but essentially a method is capable of generating a certain class of functions, of which one is chosen, that minimizes the difference between measured and predicted experimental outcomes for the training set T.
Here we describe a computer program implementing the SMM prediction method, which can be applied to model the sequence specificity of quantifiable biological processes. In such experiments, the input parameter × corresponds to a sequences of amino-or nucleic acids, and the experimental outcome ymeas is a real numbers measuring the process efficiency. The method utilizes training sets in which the examined sequences all have the same length.
The SMM method was previously applied successfully to predictions of MHC binding , TAP transport  and proteasomal cleavage . However, its software implementation was not made publicly available, because it relied on a commercial library with restrictive licensing terms. Also, applying the method to a new problem required manual changes in the source code, which is impracticable for an external user. Both of these issues are addressed in the software implementation made available here. In addition, this manuscript describes two specific features that we have found to be effective in generating high quality models and which can easily be utilized in other prediction methods, namely handling of bounded data and combinatorial peptide libraries.
The SMM software is not meant for 'classical' sequence analysis, which can be roughly defined as aligning related sequences in order to identify conserved residues or in order to generate classifiers which can identify additional related sequences. Rather, the typical application is the characterization of a sequence recognition event, such as the sequence specific cleavage efficiency of a protease. This characterization does not assume any evolutionary relationship between different recognized sequences. In terms of scientific fields, that makes the SMM software aimed at applications in biochemistry or molecular biology.
The SMM algorithm is implemented in C++ code. Only standard libraries or freely available external libraries were used. The two external libraries are Tinyxml  to handle the XML input and output and the Gnu Scientific Library  for efficient vector and matrix operations. The source code has been compiled and tested using Visual C++ on a windows system and using g++ (1.5 or above) on a Debian and Suse Linux system. A windows executable is also available. The source code, documentation and examples are available as additional files 1 and 2 of this manuscript, and on the project homepage at http://www.mhc-pathway.net/smm.
On a standard 2.6 GHz Pentium 4 PC running windows XP, the creation of a prediction tool from a typical set of training data containing 300 8-mer peptides takes about 10 minutes.
Input and output
An amino acid can be encoded as a binary vector of length 20, with zeros at all positions except the one coding for the specific amino acid. Extending this notation, a peptide of length N can be encoded as an N*20 binary vector. The same conversion can be made for nucleic residues, resulting in N*4 length vectors. Any fixed length sequence can be converted into a fixed length binary vector following similar rules. The SMM algorithm expects such a vector as the experimental input parameter 'x'.
H w = ypred (1)
From a given training set of sequences encoded in H with measured values ymeas, the 'correct' values for w can be found by minimizing the difference between the predicted values ypred and the measured values ymeas according to a norm || ||. To suppress the effect of noise in the experimental data, a second term is added to the minimization:
||H w - ymeas|| + tw Λ w → minimum, (2)
in which Λ is a positive scalar or a diagonal matrix with positive entries. To better understand the effect of the Λ term, consider first minimizing (2) with Λ set to zero. In this case, the optimal entries for the weight vector w minimize the difference between predicted (ypred) and measured (ymeas) values. Minimizing (2) with a non-zero value for Λ results in a shift of the optimal entries in w towards values closer to zero, especially for entries in w that do not significantly decrease the distance between predicted and measured values. This technique, generally called regularization, suppresses the effect of noise in the measured data ymeas on the entries in the weight vector w. Refer to  or  for a general introduction to regularization. If the || || norm is simply the sum squared error (or L2 norm), equation (2) can be solved analytically for any given value of Λ to:
w = (tHH + Λ)-1 tH ymeas (3)
The optimal value for Λ can then be determined by cross validation: The experimental data points corresponding to rows of (H, ymeas) are randomly separated into training sets Ti = (H, ymeas)train i and blind sets (H, ymeas)blind i. For a given Λ, equation (3) is used to calculate wi for each training set Ti. These wi can then be used to make predictions for their corresponding blind sets. Summing the distances for all blind predictions gives the cross validated distance Φ:
Φ(Λ) = Σi || Hblind i wi(Λ) -yblind i || (4)
Minimizing Φ as a function of Λ therefore corresponds to minimizing the cross validated distance by 'damping' the influence of coefficients in w which are susceptible to noise.
As the resulting optimal value for Λ and the corresponding wi are somewhat influenced by the split into training and blind sets, the same procedure is repeated several times with different splits, which is called bagging . The final w is generated by averaging over all optimal wi generated in the cross validation and bagging repeats.
The following sections describe specific properties of the SMM method, and are meant to serve as a guideline when and how to apply it. Additional data validating the SMM algorithm and comparing it with other prediction methods can be found in previous publications [1–3].
If no pair coefficients are incorporated, the output vector w of the SMM method is a standard 'scoring matrix', which quantifies the contribution of each residue at each position in the input sequence to the prediction. Such a matrix is easy to interpret and analyze without requiring any additional software or expert knowledge of how the matrix was generated, which is especially important when communicating results to experimentalists. Several methods predicting peptide binding to MHC molecules take this approach, e.g. [9–12], and a comparative study showed that simple statistical methods to generate matrices can perform better than more complex artificial neural networks if the amount of data is limited .
Using such a linear model implicitly assumes that the influence of residues at each position in the sequence on the measured value can be considered independent and additive. This has to be a reasonable first approximation in order to successfully apply the SMM method, even if pair coefficients are incorporated. This is the main difference to general learning algorithms such as neural networks, which can in principle model any functional relationship between sequences and measurements.
The experimental measurements that serve as input to the SMM method and the predicted output are quantitative, not binary. For example, in the case of peptide binding to MHC molecules, IC50 values quantifying binding affinities are used, and not a classification into binding and non-binding peptides.
If different representations of the quantitative data are possible, such as either IC50 or log(IC50) values, a representation should be chosen in which the ymeas values approximately follow a normal distribution. Otherwise the SMM predictions, which are sums of independent contributions and therefore roughly normally distributed themselves, will not be able to fit the experimental data well. In the case of binding affinities, this means log(IC50) values should be used, as IC50 values themselves are usually log normal distributed.
Any experimental technique generates measured values contained within a finite range. For example, in many biological experiments a "zero" measurement usually means that the actual value is below the experimental resolution, not that the actual value is 0. Similarly, very large values beyond the expected sensitivity limit are no longer quantitatively accurate. These data points at the upper or lower boundaries of the sensitivity range do not convey the same information as quantified values, but they still do contain information. In the case of MHC binding data available to us, approximately 20% of peptides fall in this category.
The L2<> norm
y pred > y meas
y pred < y meas
Quantitative (no threshold)
Upper boundary (threshold: greater)
Lower boundary (threshold: lesser)
Randomized peptide library data
As stated before, the experimental data used as input for the SMM method consists of same length amino-or nucleic acid sequences associated with a quantitative measurement. When designing an experiment, the selection of sequences to test can introduce bias into the training data, for example by over-or under-representing residues at specific sequence positions. One way to avoid this is the use of randomized peptide libraries, also known as positional scanning combinatorial peptide libraries, which are mixtures of peptides of the same length. In a given library, all peptides have one residue in common at a fixed position and a random mixture of amino acids at all other positions. For example, the library XAXXXXXX contains 8-mer peptides with a common Alanine at position 2. Such libraries can be used to directly measure the influence of their common residue, by comparing their measured process efficiency to that of the completely randomized library XXXXXXXX. In the case of 8-mer peptides, 160 library experiments are sufficient to characterize the influence of each residue at each position. The results of such a complete scan can be summarized in a scoring matrix. This approach has been used successfully in many different experimental systems [14–17]
Introducing pair coefficients
Pair coefficients quantify the contribution of a pair of residues to the measured value that deviates from the sum of their individual contributions. The form of equation (1) remains unchanged if pair coefficients are introduced in the same binary notations as the individual coefficients. Figure 2 gives an example how a set of nucleic sequences is transformed into a matrix H, if two such pair coefficients are taken into account. Note that the number of possible pair coefficients is very large. For a sequence of three nucleic acids, there are already (3*4) * (2*4) / 2 = 48 pair coefficients. For a 9-mer peptide, (9*20) * (8 * 20) / 2 = 14400 pair coefficients exist. To the best of our knowledge, only the SMM method and the additive method  explicitly quantify the influence of pair coefficients.
Since most training sets contain only a few hundred measurements, determination of the exact values of all pair coefficients is not feasible. To overcome this difficulty, the SMM algorithm limits the number of pair coefficients to be determined. First, only coefficients for which sufficient training data exists are taken into account. As a rule of thumb, 5 sequences containing the same pair of residues at the same positions have to be present in the training set for a pair coefficient to be considered. In a second filtering step, only pair coefficients for which the information in the training set is reasonably consistent are retained. In the previous SMM version, this used to be determined by multiple fitting of pair coefficients and discarding those for which a sign change was observed. In the current version, a much faster approach is used. First, a scoring matrix is calculated for the training set without any pair coefficients. Then, for each pair coefficient the predicted and measured values for the sequences containing it are compared. Only if a large enough majority (>60%) of measured values are above or below the matrix based predictions is the pair coefficient retained. The remaining pair coefficients are determined in complete analogy to the scoring matrix itself, but with a scalar Λ value.
We tested the effect of incorporating pair coefficients on prediction quality compared to using a scoring matrix alone for a number of training sets containing peptide to MHC binding data. The pair coefficients showed a consistent positive contribution for large training sets, which comprise more measurements than 1.5 times the number of scoring matrix coefficients. However, the improvement is rather small, as reported before in . This makes it reasonable to ignore pair coefficients if the simplicity of a scoring matrix is more valuable than a small improvement in prediction quality.
If higher order sequence interactions such as those described by pair coefficients are expected to be the dominant influence on experimental outcomes, other prediction methods may be better suited than the SMM method. For example, by choosing a different sequence representation than the binary vectors, the information in the training set can be generalized, thereby effectively reducing the degrees of freedom in the input parameters . This allows applying general higher order learning algorithms such as artificial neural networks even with limited input data.
The SMM method generates quantitative models of the sequence specificity of biological processes, which in turn can be used to understand and predict these processes. It has previously been shown to perform very well compared to other prediction methods and tools for three specific types of experimental data [1–3]. However, it is difficult to generalize a comparison between different methods, due to two main problems. First, the training data sets utilized in different studies are often not available, so that when comparing tools generated by different methods it is often unclear when good performance is due to a superior method or a better (larger) set of training data. Second, generating tools from the same training set can be difficult, because publications that make the tools available, often only describe the basic principle of the method used.
To overcome this second obstacle, we herein presented a computer program implementing the SMM method. Significant effort was devoted to ensuring that the program is robust, documented, cross platform compatible and generates reasonable output without requiring additional parameters. Also, any commercial libraries previously utilized were removed to allow free distribution of the code. This will permit any interested user to apply the SMM method with reasonable effort, allowing for the most important validation: application to scientific practice.
Finally, we believe that two strategies demonstrated in this manuscript will be valuable in combination with other prediction methods as well. First, our strategy for the inclusion of experimental data gathered with randomized peptide libraries can be directly transferred to any prediction method. When other experimental data is limited and data from a combinatorial library is available, this should always have a positive effect on prediction quality. Secondly, the L2<> norm can be applied as an error function for other prediction methods. This will increase the amount of training data effectively available to prediction methods requiring quantitative input, by enabling them to handle experimental boundary values.
Project name: smm
Project home page: http://www.mhc-pathway.net/smm
Operating system(s): Platform independent
Programming language: C++
Other requirements: The Gnu Scientific Library (GSL) has to be installed
License: None for the smm code, but GSL requires the GNU GPL license
Any restrictions to use by non-academics: None
The authors want to acknowledge the help of Emrah Kostem in adopting the source code to g++ and John Sidney for critically reading the manuscript. This work was supported by the National Institutes of Health Contract HHSN26620040006C
- Peters B, Tong W, Sidney J, Sette A, Weng Z: Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 2003, 19: 1765–1772. 10.1093/bioinformatics/btg247View ArticlePubMedGoogle Scholar
- Peters B, Bulik S, Tampe R, Van Endert PM, Holzhutter HG: Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol 2003, 171: 1741–1749.View ArticlePubMedGoogle Scholar
- Tenzer S, Peters B, Bulik S, Schoor O, Lemmel C, Schatz MM, Kloetzel PM, Rammensee HG, Schild H, Holzhutter HG: Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding. Cell Mol Life Sci 2005, 62: 1025–1037. 10.1007/s00018-005-4528-2View ArticlePubMedGoogle Scholar
- Thomason L: TinyXml.[http://sourceforge.net/projects/tinyxml/]
- Gnu Scientific Library (GSL)[http://www.gnu.org/software/gsl/]
- Orr MJL: Introduction to Radial Basis Function Networks.[http://www.anc.ed.ac.uk/~mjo/papers/intro.ps]
- Press WH, Teukolsky SA, Vetterling WT, Flannery BP: Numerical Recipes in C. 2nd edition. , Cambridge University Press; 1992.Google Scholar
- Breiman L: Bagging Predictors. Machine Learning 1996, 24: 123–140.Google Scholar
- Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994, 152: 163–175.PubMedGoogle Scholar
- Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50: 213–219. 10.1007/s002510050595View ArticlePubMedGoogle Scholar
- Sidney J, Dzuris JL, Newman MJ, Johnson RP, Kaur A, Amitinder K, Walker CM, Appella E, Mothe B, Watkins DI, Sette A: Definition of the Mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins. J Immunol 2000, 165: 6387–6399.View ArticlePubMedGoogle Scholar
- Lauemoller SL, Holm A, Hilden J, Brunak S, Holst Nissen M, Stryhn A, Ostergaard Pedersen L, Buus S: Quantitative predictions of peptide binding to MHC class I molecules using specificity matrices and anchor-stratified calibrations. Tissue Antigens 2001, 57: 405–414. 10.1034/j.1399-0039.2001.057005405.xView ArticlePubMedGoogle Scholar
- Yu K, Petrovsky N, Schonbach C, Koh JY, Brusic V: Methods for prediction of peptide binding to MHC molecules: a comparative study. Mol Med 2002, 8: 137–148.PubMed CentralPubMedGoogle Scholar
- Pinilla C, Martin R, Gran B, Appel JR, Boggiano C, Wilson DB, Houghten RA: Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol 1999, 11: 193–202. 10.1016/S0952-7915(99)80033-8View ArticlePubMedGoogle Scholar
- Uebel S, Kraas W, Kienle S, Wiesmuller KH, Jung G, Tampe R: Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. Proc Natl Acad Sci U S A 1997, 94: 8976–8981. 10.1073/pnas.94.17.8976PubMed CentralView ArticlePubMedGoogle Scholar
- Udaka K, Wiesmuller KH, Kienle S, Jung G, Tamamura H, Yamagishi H, Okumura K, Walden P, Suto T, Kawasaki T: An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics 2000, 51: 816–828. 10.1007/s002510000217View ArticlePubMedGoogle Scholar
- Nazif T, Bogyo M: Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors. Proc Natl Acad Sci U S A 2001, 98: 2967–2972. 10.1073/pnas.061028898PubMed CentralView ArticlePubMedGoogle Scholar
- Doytchinova IA, Blythe MJ, Flower DR: Additive Method for the Prediction of Protein-Peptide Binding Affinity. Application to the MHC Class I Molecule HLA-A*0201. Journal of Proteome Research 2002, 1: 263–272. 10.1021/pr015513zView ArticlePubMedGoogle Scholar
- Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, Brunak S, Lund O: Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003, 12: 1007–1017. 10.1110/ps.0239403PubMed CentralView ArticlePubMedGoogle Scholar
- Daniel S, Brusic V, Caillat-Zucman S, Petrovsky N, Harrison L, Riganelli D, Sinigaglia F, Gallazzi F, Hammer J, van Endert PM: Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol 1998, 161: 617–624.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.